Expand BIO Menu
BIO MENU

Bio-Rad Laboratories Class A (BIO) closed at $366.36 on November 13, 2026, down 1.1% from the previous close, on volume of 246,167 shares (30-day average 233,010).

Key numbers
  • Last close: $366.36 (November 13, 2026)
  • 52-week range: $236.73 to $396.23
  • Market value: $9.9 billion
  • 30-day implied volatility (IV30): 34.8%
  • Option volume: 1,027 contracts (1,026 calls, 1 puts); 30-day average 178

Data as of November 13, 2026.

BIO Stock Summary and Trading Ideas (Bio-Rad Laboratories Class A | NYSE:BIO)

Charts for Today's Stock Price and Implied Volatility in Bio-Rad Laboratories Class A

13-Nov-2026

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for BIO by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Bio-Rad Laboratories Class A (BIO) Frequently Asked Questions

What does Bio-Rad Laboratories Class A do?

Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.

What symbol and exchange does Bio-Rad Laboratories Class A shares trade?

Bio-Rad Laboratories Class A trades on the NYSE stock market under the symbol BIO.

What is Bio-Rad Laboratories Class A stock price doing today?

As of November 13, 2026, BIO stock price declined to $366.36 with 246,167 million shares trading.

What is Bio-Rad Laboratories Class A's Beta?

BIO has a beta of 0.74, meaning it tends to be less sensitive to market movements. BIO has a correlation of 0.07 to the broad based SPY ETF.

How much is Bio-Rad Laboratories Class A worth?

BIO has a market cap of $9.88 billion. This is considered a Mid Cap stock.

How much money does Bio-Rad Laboratories Class A make?

Last quarter Bio-Rad Laboratories Class A reported $656 million in Revenue and $2.65 earnings per share. This beat revenue expectation by $4 million and exceeded earnings estimates by $.35.

What is the highest and lowest price Bio-Rad Laboratories Class A traded in the last 3 year period?

In the last 3 years, BIO traded as high as $396.23 and as low as $211.43.

What are the top ETFs holding Bio-Rad Laboratories Class A?

The top ETF exchange traded funds that BIO belongs to (by Net Assets): IJH, VTI, DFSV, VB, VBR.

Is Bio-Rad Laboratories Class A (BIO) a good investment?

BIO has outperformed the market in the last year with a return of +15.6%, while the SPY ETF gained +13.4%. In the last 3 month period, BIO beat the market returning +1.4%, while SPY returned -2.8%. However, in the most recent 2 weeks BIO has underperformed the stock market by returning -1.6%, while SPY returned -0.2%.

What are the support and resistance levels for Bio-Rad Laboratories Class A (BIO)?

BIO support price is $361.56 and resistance is $379.40 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BIO shares will trade within this expected range on the day.

Market Data Delayed 15 Minutes